How a National Risk Pool Can Transform Gene & Cell Therapies

For patients suffering from rare, debilitating diseases, cell and gene therapies offer a source of hope. These innovative treatments are tailored to individual patients’ DNA, which makes them uniquely effective. But there is one major problem – the staggeringly high price tag.

It’s Too Early to Claim Victory on Raising the MA Quality Bar 

ACHP’s MA for Tomorrow policy proposals raise the quality bar and modernize the stars rating, empowering seniors to make more informed choices while rewarding truly high-performing plans. It’s past time we focused on what matters to seniors – their experience and health – and prioritize these measures in star ratings.

icon-arrow
client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo client-logo
icon-arrow